Tuberculosis News and Research

Latest Tuberculosis News and Research

WHO declares updates to forthcoming guidance on systematic screening for TB

In a Rapid Communication issued today, the World Health Organization (WHO) is announcing a number of updates to its forthcoming guidance on the systematic screening of tuberculosis (TB) disease.

7 Dec 2020

Vaccination against tuberculosis has influence on the epidemiology of COVID-19

St Petersburg University scientists have analyzed about 100 academic papers and statistics on the incidence of COVID-19 in different countries of the world.

3 Dec 2020

Global solidarity, resilient services to reduce TB deaths among people living with HIV

The theme of this year's World AIDS Day is "Global solidarity, resilient services". At the 2016 UN High-level Meeting on ending AIDS, member states committed to a 75% reduction of TB deaths among people living with HIV by 2020, compared with 2010.

2 Dec 2020

New reviews provide timely updates for scholars, professionals focused on antimicrobial research

The initial chapter of 'Anti-infective Research and Development: Updates on Infection Mechanisms and Treatments' covers the mode of action of natural antimycobacterial compounds such as nordihydroguaiaretic acid, α-mangostin and allicin, as well as antimicrobial peptides and their role in the innate and adaptive immune response leading to the decrease of microbial resistance.

1 Dec 2020

Researchers reveal how SARS-CoV-2 reaches the brain

Using post-mortem tissue samples, a team of researchers from Charité - Universitätsmedizin Berlin have studied the mechanisms by which the novel coronavirus can reach the brains of patients with COVID-19, and how the immune system responds to the virus once it does.

30 Nov 2020

HIV and TB laboratory systems used to scale up COVID-19 testing in Africa

Many countries in resource-limited settings have high HIV, malaria, tuberculosis, hepatitis, and/or sexually transmitted infection (STI) burdens.

30 Nov 2020

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

University of California San Diego Collaborative Clinical Trials Unit has been selected by the National Institutes of Health to lead and administer an international seven-year, $28-million grant for science-driven clinical trials that deliver innovative, efficient results needed to turn the corner on the HIV/AIDS pandemic.

30 Nov 2020

Mollusc-derived compounds potential medicines for COVID-19 and other respiratory diseases

A research team has reviewed the existing literature on compounds derived from molluscs used for treating respiratory diseases.

30 Nov 2020

TDR and WHO develop interactive web-based research toolkit for TB care

TDR, in partnership with the WHO Global Tuberculosis Programme, has developed an interactive web-based toolkit that supports national TB programmes and other partners to conduct implementation research designed to evaluate digital technologies for TB care.

30 Nov 2020

Overcoming pediatric drug-resistant TB crisis

World Children's Day marks the day, over three decades ago, on which world leaders adopted the historic Convention of the Rights of the Child, promising to every child to promote and protect their rights, including the right to life and the right to health.

30 Nov 2020

MARA project aims to use new DNA based nanotechnology to fight bacteria

Antibiotics are used to prevent and treat bacterial infections. They have played a major role in combating infectious diseases such as tuberculosis, pneumonia, typhoid fever, and meningitis in 20th century.

27 Nov 2020

Otsuka Pharmaceutical enters into global agreement with Columbia University School of Public Health

Otsuka Pharmaceutical Development & Commercialization, Inc., announced an agreement with research experts from the Columbia University Irving Center Vagelos College of Physicians and Surgeons and Mailman School of Public Health to help support the epidemiological needs of Otsuka Global Pharmacovigilance (GPV) for products, enhanced training, and employee education.

25 Nov 2020

Researchers develop lung-on-chip model to study the body’s response to early TB

Scientists have developed a lung-on-chip model to study how the body responds to early tuberculosis (TB) infection, according to findings published today in eLife.

25 Nov 2020

BCG vaccination appears to trigger cross-reactive SARS-CoV-2-specific T cell response

Recently, researchers from the Monash University and Monash Medical Centre, Clayton, Victoria, Australia, investigated whether peptide sensitization using BCG can produce cross-reactive T cells specific to SARS-CoV-2. Their study is published on the preprint server, medRxiv.

24 Nov 2020

American Lung Association strongly recommends everyone to celebrate Thanksgiving at home

In response to surging COVID-19 cases and deaths as we head into the Thanksgiving holiday, the Centers for Disease Control and Prevention has recommended Americans refrain from traveling to prevent the spread of COVID-19.

24 Nov 2020

Texas Biomed awarded $1 million to evaluate MAb therapeutics for COVID-19

Texas Biomedical Research Institute in San Antonio, Texas, was awarded $1 million from the Bill & Melinda Gates Foundation to test the efficacy of human monoclonal antibodies (MAbs) for the treatment of SARS-CoV-2 infection.

19 Nov 2020

TB researchers uncover crucial clue that explains antibiotic resistance in bacteria

For a slow-growing microbe that multiplies infrequently, Mycobacterium tuberculosis, the pathogen that causes tuberculosis (TB) has long puzzled researchers as to how it develops resistance to antibiotics so quickly, in a matter of weeks to months.

18 Nov 2020

Existing UV light technology has potential to be effective against Covid-19

A recent study has shown that a UV light technology already used to prevent the spread of other airborne diseases in buildings has the potential to be effective against Covid-19.

17 Nov 2020

Multi-faceted COVID-19 strategy can prevent infections, save lives in resource-challenged countries

A public health strategy that combines contact tracing and community-based screening with isolation and quarantine centers can substantially reduce infections, hospitalizations and deaths from COVID-19 while being cost-effective in low-and-middle-income countries like South Africa, a study by Massachusetts General Hospital has found.

15 Nov 2020

High prevalence of cross-reactive anti-SARS-CoV-2 antibodies in sub-Saharan Africa

A recent study published in the International Journal of Infectious Diseases has explained the lower prevalence of coronavirus disease 2019 (COVID-19) in sub-Saharan Africa compared to that in the US, Europe, and Asia.

15 Nov 2020

Tuberculosis News and Research

Latest Tuberculosis News and Research

WHO declares updates to forthcoming guidance on systematic screening for TB

Vaccination against tuberculosis has influence on the epidemiology of COVID-19

Global solidarity, resilient services to reduce TB deaths among people living with HIV

New reviews provide timely updates for scholars, professionals focused on antimicrobial research

Researchers reveal how SARS-CoV-2 reaches the brain

HIV and TB laboratory systems used to scale up COVID-19 testing in Africa

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

Mollusc-derived compounds potential medicines for COVID-19 and other respiratory diseases

TDR and WHO develop interactive web-based research toolkit for TB care

Overcoming pediatric drug-resistant TB crisis

MARA project aims to use new DNA based nanotechnology to fight bacteria

Otsuka Pharmaceutical enters into global agreement with Columbia University School of Public Health

Researchers develop lung-on-chip model to study the body’s response to early TB

BCG vaccination appears to trigger cross-reactive SARS-CoV-2-specific T cell response

American Lung Association strongly recommends everyone to celebrate Thanksgiving at home

Texas Biomed awarded $1 million to evaluate MAb therapeutics for COVID-19

TB researchers uncover crucial clue that explains antibiotic resistance in bacteria

Existing UV light technology has potential to be effective against Covid-19

Multi-faceted COVID-19 strategy can prevent infections, save lives in resource-challenged countries

High prevalence of cross-reactive anti-SARS-CoV-2 antibodies in sub-Saharan Africa

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in